More recently, on July 9, 2001, a letter from the current Secretary of Health and Human Services, Tommy Thompson, indicated that based on an analysis by the Food and Drug Administration on the safety issues and analysis by his planning office on the cost issues, he could not make the required determinations, and he stated his view that we should not sacrifice public safety for uncertain speculative cost savings. Secretary Thompson also indicated that prescription drug safety could not be adequately guaranteed if drug reimportation were allowed and that costs associated with documentation, sampling, and testing of imported drugs would make it difficult for consumers to get any significant price savings.
Editor's note · Context
Discussing a letter from Secretary of Health and Human Services regarding drug reimportation and public safety.
Share
More from Thad Cochran
We appreciate that the Defense Appropriations Subcommittee and the Senate play important roles in crafting the annual eligible conditions list.
I am pleased to commend LTC Daniel S. Artino for his dedication to duty and service as an Army legislative fellow and congressional budget liaison for the Assistant Secretary of the Army. Dan was recently selected to command an Apache…
I understand that the Army's unfunded requirements list includes a $3.1 billion increase in end strength beyond the fiscal year 2017 NDAA mandate.
Ensuring that the Corps has adequate funding to meet its responsibilities is a high priority of mine.





